Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
The FEBS Journal|November 20, 2025
Moderate increase of MET in hepatocytes protects against cholestatic liver injury by promoting an effective antioxidant responseCarlos González-Corralejo, Juan García-Sáez, María Figueroa-Fuentes, et al.
The Journal of Pathology|June 14, 2024
The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic nicheEster Gonzalez-Sanchez, Javier Vaquero, Daniel Caballero-Diaz, et al.
Free Radical Biology & Medicine|February 23, 2018
Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysmFrancesc Jiménez-Altayó, Thayna Meirelles, Eva Crosas-Molist, et al.
Stem Cells (Dayton, Ohio)|May 21, 2019
c-Met Signaling Is Essential for Mouse Adult Liver Progenitor Cells Expansion After Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition and Regulates Cell Phenotypic SwitchLaura Almalé, María García-Álvaro, Adoración Martínez-Palacián, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2014
A trifluorinated thiazoline scaffold leading to pro-apoptotic agents targeting prohibitinsAlba Pérez-Perarnau, Sara Preciado, Claudia Mariela Palmeri, et al.
The Journal of Pathology|September 23, 2022
Lack of EGFR catalytic activity in hepatocytes improves liver regeneration following DDC-induced cholestatic injury by promoting a pro-restorative inflammatory responseNerea Lazcanoiturburu, Juan García-Sáez, Carlos González-Corralejo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 17, 2015
Vascular smooth muscle cell phenotypic changes in patients with Marfan syndromeEva Crosas-Molist, Thayna Meirelles, Judit López-Luque, et al.
Hepatology (Baltimore, Md.)|August 28, 2015
Dissecting the role of epidermal growth factor receptor catalytic activity during liver regeneration and hepatocarcinogenesisJudit López-Luque, Daniel Caballero-Díaz, Adoración Martinez-Palacián, et al.
Signal Transduction and Targeted Therapy|August 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblastsJosep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome, et al.
Cell Death & Disease|May 29, 2021
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activityPablo Fernández-Tussy, Rubén Rodríguez-Agudo, David Fernández-Ramos, et al.
Pageof 13